301130.SZ Stock Analysis
30
Uncovered
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Moderate score
Jilin Province Xidian Pharmaceutical Sci-Tech Dev Co., Ltd. engages in the research, development and sale of chemical raw materials and preparations. The company is headquartered in Jilin, Jilin and currently employs 279 full-time employees. The company went IPO on 2022-02-23. The firm's products cover the fields of anti anemia drugs, drugs for the treatment of mental disorders and the production of APIs, such as compound ferrous sulfate folic acid tablets, risperidone orally disintegrating tablets, escitalopram oxalate tablets, daphnetin capsules, sodium ferulate and ferrous fumarate.